MRK vs PODD
By Alex · Tickerpine
Merck & Co., Inc. vs Insulet Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | PODD |
|---|---|---|
| Price | $148.78 | $136.13 |
| Market cap | $367.07B | $9.44B |
| P/E ratio | 119.0 | 25.5 |
| ROE | 6.96% | 26.02% |
| Profit margin | 4.77% | 12.29% |
| Revenue growth | 5.10% | 23.50% |
| Dividend yield | 2.29% | — |
| Beta | 0.23 | 1.08 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs PODD in plain English
- MRK is the bigger company — about 38.9× the market cap of PODD.
- PODD is cheaper on earnings (P/E 25.5 vs 119.0).
- PODD earns a higher return on equity (26% vs 7%).
- PODD is growing revenue faster (24% vs 5%).
- MRK pays a dividend (2.29%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
PODD return calculator
See what $1,000 in Insulet Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.